Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyskinesia, Medication-induced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Testing effectiveness (Phase 2)Ended earlyNCT01789047
What this trial is testing

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseDrug Induced Dyskinesia
Rush University Medical Center 42
Not applicableStudy completedNCT01467089
What this trial is testing

The Assessment of Movement Disorders Utilizing Live Two-Way Video

Who this might be right for
Tardive Dyskinesia
Northwell Health 37
Large-scale testing (Phase 3)Study completedNCT00672373
What this trial is testing

Extract of Ginkgo Biloba and Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaSchizophrenia
Beijing HuiLongGuan Hospital 157
Large-scale testing (Phase 3)WithdrawnNCT01908452
What this trial is testing

Pyridoxal Kinase Activity in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center
Testing effectiveness (Phase 2)Looking for participantsNCT07365462
What this trial is testing

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 100
Early research (Phase 1)Study completedNCT06216054
What this trial is testing

Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects

Who this might be right for
Tardive DyskinesiaHuntington Disease
Luye Pharma Group Ltd. 40
Post-approval studies (Phase 4)Looking for participantsNCT03495024
What this trial is testing

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Who this might be right for
SchizophreniaSchizoaffective DisorderTobacco Smoking+2 more
Corporal Michael J. Crescenz VA Medical Center 10
Large-scale testing (Phase 3)Study completedNCT03176771
What this trial is testing

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Tanabe Pharma Corporation 256
Post-approval studies (Phase 4)Study completedNCT00926965
What this trial is testing

Tardive Dyskinesia and Cognitive Function

Who this might be right for
Tardive DyskinesiaNeurocognitive Function
Taipei Veterans General Hospital, Taiwan 80
Large-scale testing (Phase 3)Study completedNCT02291861
What this trial is testing

Addressing Involuntary Movements in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 298
Post-approval studies (Phase 4)Study completedNCT03891862
What this trial is testing

Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Neurocrine Biosciences 135
Testing effectiveness (Phase 2)Study completedNCT05297201
What this trial is testing

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-Induced
Celon Pharma SA 105
Large-scale testing (Phase 3)Study completedNCT01543321
What this trial is testing

Xenazine in Late Dyskinetic Syndrome With Neuroleptics

Who this might be right for
Tardive Dyskinesia
Centre Hospitalier Universitaire, Amiens 54
Post-approval studies (Phase 4)Study completedNCT00621998
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-Induced Tardive Dyskinesia
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableUnknownNCT02840760
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.

Who this might be right for
Tardive Dyskinesia
Shanghai Mental Health Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06731868
What this trial is testing

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Luye Pharma Group Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT01474421
What this trial is testing

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Who this might be right for
DyskinesiasDrug-induced
Novartis Pharmaceuticals 71
Not applicableNot Yet RecruitingNCT06218719
What this trial is testing

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Who this might be right for
Tardive Dyskinesia
Power Life Sciences Inc. 500
Next Page